Women's Health News

RSS

Scientific evidence found linking second-hand smoke exposure to pre-menopausal breast cancer

Until recently, the evidence surrounding the link between breast cancer and tobacco smoke was inconclusive. Now, according to an international panel of experts convened by the Ontario Tobacco Research Unit (OTRU) sufficient scientific evidence exists linking second-hand smoke exposure to pre-menopausal breast cancer and active smoking to breast cancer in women of all ages.

4 Nov 2009

Abortion continues to snag health reform legislation, divide lawmakers

The divisive issue of abortions, a lingering hurdle to health reform legislation, is plaguing both House and Senate Democratic leaders, the Los Angeles Times reports. "The delays in both houses reflect the fact that even though Democrats hold solid majorities, significant divisions exist below the surface.

4 Nov 2009

Majority of women smokers unaware of immediate and long term health risks

Many women are aware that smoking can lead to lung cancer, heart disease and premature death. But a recent survey conducted by Angus Reid on behalf of nicotine replacement therapy brands, NICODERM(R) and NICORETTE(R) reveals that the majority of Canadian women who smoke are not necessarily aware of the host of other impacts that smoking can have on their immediate and longer term health.

4 Nov 2009

40 Days for Life prays before Planned Parenthood abortion center, director quits

The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.

4 Nov 2009

Higher testosterone levels in older women are associated with increased health risks

Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

4 Nov 2009

Stress-reduction workshops for women with history of breast cancer

Are you stressed? Do you have a family history of breast cancer? Health SMART is a study is being conducted by researchers at Fred Hutchinson Cancer Research Center to see how stress-reduction workshops can help women with a family history of breast cancer manage their everyday stresses and cancer-risk concerns.

4 Nov 2009

New advanced fertility monitor for women

1 in 6 British couples now face problems conceiving, so maximising the chances of natural conception by identifying precisely when ovulation occurs is critical.

4 Nov 2009

Weightlifting increases self-esteem among breast cancer survivors: Study

In addition to building muscle, weightlifting is also a prescription for self-esteem among breast cancer survivors, according to new University of Pennsylvania School of Medicine research. Breast cancer survivors who lift weights regularly feel better about bodies and their appearance and are more satisfied with their intimate relationships compared with survivors who do not lift weights, according to a new study published in the journal Breast Cancer Research and Treatment.

4 Nov 2009

Obese women less likely to become pregnant and have successful pregnancy, says new findings

Obese women are as much as 28 percent less likely to become pregnant and have a successful pregnancy, according to research that earned a Michigan State University professor a national award.

4 Nov 2009

HER2-positive breast cancer patients can be treated with Trastuzumab and adjuvant radiation therapy

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)--typically used in combination with chemotherapy.

4 Nov 2009

Breastfeeding: ADA position paper details health benefits for both infants and mothers

The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.

4 Nov 2009

Also in Global Health News: Breast cancer in developing world; Burkina Faso ITN distribution; diarrhea in people over age five; Gates Q&A

"International cancer specialists meet this week to plan an assault on a troubling increase of breast cancer in developing countries, where nearly two-thirds of women aren't diagnosed until it has spread through their bodies," the Associated Press reports. Researchers will also look at "some worrisome data" that suggests breast cancer affects "women, on average, about 10 years" earlier in developing countries than it does in the U.S. (Neergaard, 11/3).

3 Nov 2009

Vaccinating mothers against influeza during pregnancy prevents hospitalization in their infants

Infants born to women who received influenza vaccine during pregnancy were hospitalized at a lower rate than infants born to unvaccinated mothers, according to preliminary results of an ongoing study by researchers at Yale School of Medicine. The team presented the study October 29 at the 47th annual meeting of the Infectious Diseases Society of America in Philadelphia.

3 Nov 2009

A new blood test for breast cancer

A healthy 44-year-old woman will celebrate many future birthdays thanks to the efforts of Dr. Keri Sweeten and a new blood test for breast cancer

3 Nov 2009

Study reveals high risk of recurrence for early-stage breast cancer patients with HER2 positive tumors

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

3 Nov 2009

IMC-RT does not benefit breast cancer patients

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

3 Nov 2009

Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response

Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

3 Nov 2009

New imaging technique for treatment of breast cancer

Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy. The study is examining the utility of three-dimensional thermal tomography in radiation oncology.

3 Nov 2009

NIH awards $1.2 million to GE Global Research to develop a low-cost transducer

In the quest to expand access to high quality prenatal care to communities with limited healthcare services, GE Global Research, the technology development arm for the General Electric Company, has been awarded a two-year, $1.2 million project under the federal stimulus program from the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health (NIH) to develop a low-cost transducer for portable ultrasound systems that maintains the highest degree of image quality.

2 Nov 2009

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.

2 Nov 2009

Women's Health News

Scientific evidence found linking second-hand smoke exposure to pre-menopausal breast cancer

Abortion continues to snag health reform legislation, divide lawmakers

Majority of women smokers unaware of immediate and long term health risks

40 Days for Life prays before Planned Parenthood abortion center, director quits

Higher testosterone levels in older women are associated with increased health risks

Stress-reduction workshops for women with history of breast cancer

New advanced fertility monitor for women

Weightlifting increases self-esteem among breast cancer survivors: Study

Obese women less likely to become pregnant and have successful pregnancy, says new findings

HER2-positive breast cancer patients can be treated with Trastuzumab and adjuvant radiation therapy

Breastfeeding: ADA position paper details health benefits for both infants and mothers

Also in Global Health News: Breast cancer in developing world; Burkina Faso ITN distribution; diarrhea in people over age five; Gates Q&A

Vaccinating mothers against influeza during pregnancy prevents hospitalization in their infants

A new blood test for breast cancer

Study reveals high risk of recurrence for early-stage breast cancer patients with HER2 positive tumors

IMC-RT does not benefit breast cancer patients

Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response

New imaging technique for treatment of breast cancer

NIH awards $1.2 million to GE Global Research to develop a low-cost transducer

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News